{"id":"https://openalex.org/W2198621908","doi":null,"title":"Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb.","display_name":"Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb.","publication_year":1998,"publication_date":"1998-06-01","ids":{"openalex":"https://openalex.org/W2198621908","mag":"2198621908","pmid":"https://pubmed.ncbi.nlm.nih.gov/9660044"},"language":"en","primary_location":{"id":"pmid:9660044","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9660044","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"A Madej","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166182418","display_name":"Medical University of Silesia","ror":"https://ror.org/005k7hp45","country_code":"PL","type":"education","lineage":["https://openalex.org/I166182418"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"A Madej","raw_affiliation_strings":["Department of Clinical Pharmacology, Silesian Medical University, Katowice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Silesian Medical University, Katowice, Poland","institution_ids":["https://openalex.org/I166182418"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009237297","display_name":"Bogus\u0142aw Okopie\u0144","orcid":"https://orcid.org/0000-0001-7228-2906","observed_orcids":["https://orcid.org/0000-0001-7228-2906"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Okopien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028395075","display_name":"Jan Kowalski","orcid":"https://orcid.org/0000-0001-6455-4502","observed_orcids":["https://orcid.org/0000-0001-6455-4502"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Kowalski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110049778","display_name":"M Zieli\u0144ski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Zielinski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J Wysocki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Wysocki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072867969","display_name":"Bozena Szygu\u0142a","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Szygula","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020168295","display_name":"Zbigniew Kalina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z Kalina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110401283","display_name":"Zbigniew S. Herman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z S Herman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.0033,"has_fulltext":false,"cited_by_count":152,"citation_normalized_percentile":{"value":0.94613767,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"36","issue":"6","first_page":"345","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8241999745368958,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8241999745368958,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.15839999914169312,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-iib-hyperlipoproteinemia","display_name":"type IIb hyperlipoproteinemia","score":0.8769999742507935},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.9909999966621399},{"id":"https://openalex.org/keywords/plasma-cytokine-levels","display_name":"plasma cytokines","score":0.9459999799728394},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8980000019073486},{"id":"https://openalex.org/keywords/interleukin-1","display_name":"interleukin-1","score":0.996999979019165},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.9359999895095825},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.640999972820282},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.902999997138977},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.746999979019165},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9509999752044678},{"id":"https://openalex.org/keywords/inflammation-in-atherosclerosis","display_name":"inflammation in atherosclerosis","score":0.7879999876022339},{"id":"https://openalex.org/keywords/monocytes-macrophages","display_name":"monocytes/macrophages","score":0.7129999995231628},{"id":"https://openalex.org/keywords/t-cells","display_name":"T cells","score":0.9879999756813049}],"concepts":[{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.9446792602539062},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7619690895080566},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.698728084564209},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6937347650527954},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6534909009933472},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.5693967342376709},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5398380756378174},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.45366954803466797},{"id":"https://openalex.org/C57089818","wikidata":"https://www.wikidata.org/wiki/Q424728","display_name":"Apolipoprotein E","level":3,"score":0.43700915575027466},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.42877477407455444},{"id":"https://openalex.org/C2780841837","wikidata":"https://www.wikidata.org/wiki/Q24741149","display_name":"Interferon gamma","level":3,"score":0.42148345708847046},{"id":"https://openalex.org/C11988809","wikidata":"https://www.wikidata.org/wiki/Q412889","display_name":"Interleukin 6","level":3,"score":0.41206246614456177},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34844398498535156},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.11740642786026001}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001161","descriptor_name":"Arteriosclerosis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001161","descriptor_name":"Arteriosclerosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001161","descriptor_name":"Arteriosclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007375","descriptor_name":"Interleukin-1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9660044","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9660044","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Clinical Trial"},{"id":"mag:2198621908","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9660044","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2405913405","https://openalex.org/W125849861","https://openalex.org/W7096482861","https://openalex.org/W2043483360","https://openalex.org/W2322011614","https://openalex.org/W2077160037","https://openalex.org/W2071586652","https://openalex.org/W7097244621","https://openalex.org/W2056319820","https://openalex.org/W1989014683"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"OBJECTIVE:":[2],"In":[3],"recent":[4],"studies":[5],"atherosclerosis":[6],"has":[7],"often":[8],"been":[9],"referred":[10],"to":[11,61,183,294],"as":[12,146],"immune":[13],"disease.":[14,139],"The":[15,55,141,302,320],"atherosclerotic":[16,131,225,251,270],"plaque":[17],"consists":[18],"of":[19,22,57,66,83,92,177,265,305,315,322],"large":[20],"amounts":[21],"inflammatory":[23,138],"cells,":[24],"mainly":[25],"monocytes/macrophages":[26],"and":[27,42,76,112,133,166,211,236,279,308,317,329,341,349],"T":[28,49],"lymphocytes.":[29],"Macrophages":[30],"activated":[31],"by":[32,120],"low-density":[33],"lipoproteins":[34],"(LDL)":[35],"secrete":[36],"tumor":[37],"necrosis":[38],"factor":[39],"alpha":[40],"(TNF-alpha)":[41],"interleukin-1":[43],"(IL-1)":[44],"in":[45,70,85,224,230,250,269,332,338,346,351],"vitro,":[46],"while":[47],"LDL-stimulated":[48],"lymphocytes":[50],"release":[51],"interferon":[52],"gamma":[53],"(IFN-gamma).":[54],"aim":[56],"this":[58,323],"study":[59,324],"was":[60],"estimate":[62],"the":[63,79,90,95,115,121,180,184,262,312],"plasma":[64,327],"levels":[65,117,223,249,264,292,304,314,331],"TNF-alpha,":[67],"IL-1,":[68],"IFN-gamma":[69,266,291,330],"patients":[71,100,132,226,252,271,334],"with":[72,101,105,136,273,311],"hyperlipoproteinemia":[73],"IIb":[74],"(HLPIIb)":[75],"atherosclerosis.":[77],"Since":[78],"fibrates":[80,93],"are":[81,335],"drugs":[82],"choice":[84],"HLPIIb,":[86],"we":[87,129],"additionally":[88],"evaluated":[89],"effect":[91],"on":[94],"cytokine":[96,116,127],"levels.":[97],"METHODS:":[98],"Ten":[99],"HLPIIb":[102],"were":[103,118,145,227,253,267],"treated":[104],"micronized":[106],"fenofibrate":[107,178,289,343],"for":[108],"1":[109,175],"month.":[110],"Before":[111,220],"after":[113],"treatment,":[114],"measured":[119],"ELISA":[122],"method.":[123],"To":[124],"accurately":[125],"evaluate":[126],"levels,":[128],"excluded":[130],"control":[134,231],"subjects":[135],"any":[137],"RESULTS:":[140],"initial":[142,263],"lipid":[143],"parameters":[144,181],"follows:":[147],"total":[148],"cholesterol":[149],"(TC):":[150],"6.9":[151],"+/-":[152,158,163,171,189,197,205,214,234,238,255,277,281,296],"0.24":[153],"mmol/l,":[154,160,165],"triglycerides":[155],"(TG):":[156],"3.44":[157],"0.53":[159],"LDL:":[161],"4.35":[162],"0.12":[164],"apolipoprotein":[167],"B":[168],"(ApoB):":[169],"1.62":[170],"0.05":[172],"g/l.":[173],"After":[174,245,288],"month":[176],"treatment":[179],"decreased":[182,293,303,313],"following":[185],"values:":[186],"TC":[187],"5.36":[188],"0.42":[190],"mmol/l":[191,199,216],"(p":[192,200,208,217,242,258,285,299],"<":[193,201,209,243,259,286,300],"0.05),":[194,202],"TG":[195],"1.94":[196],"0.30":[198],"ApoB":[203],"1.43":[204],"0.04":[206],"g/l":[207],"0.01),":[210],"LDL":[212,309],"3.75":[213],"0.34":[215],">":[218],"0.05).":[219],"therapy,":[221,247,290],"TNF-alpha":[222,248,316,328],"higher":[228,268,336],"than":[229,337],"subjects,":[232,275,340],"19.2":[233],"1.6":[235],"9.9":[237],"1.1":[239],"pg/ml,":[240,283],"respectively":[241,284],"0.01).":[244,260,287,301],"1-month":[246],"9.2":[254],"1.0":[256],"pg/ml":[257,298],"Similarly,":[261],"compared":[272],"healthy":[274,339],"44.4":[276],"5.3,":[278],"19.4":[280],"2.1":[282],"24.8":[295],"2.9":[297],"TC,":[306],"TG,":[307],"correlated":[310],"IFN-gamma.":[318],"CONCLUSION:":[319],"results":[321],"indicate":[325],"that":[326,342],"hyperlipidemic":[333],"is":[344],"effective":[345],"decreasing":[347],"lipids":[348],"cytokines":[350],"plasma.":[352]},"counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}